SMTL ID : 7k8r.1

Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C135

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-1-1-mer

Ligands

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 8 residues within 4Å: Chain A: G.101, Y.102, L.103, H.105 Chain B: L.46, Y.49, E.55 Ligands: GOL.3 4 PLIP interactions: 2 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:Y.102, A:L.103, B:E.55, B:E.55 GOL.2: 13 residues within 4Å: Chain A: F.172, P.173, A.174, V.175, S.183, L.184, S.185 Chain B: Q.160, E.161, S.162, S.176, S.177, T.178 4 PLIP interactions: 1 interactions with chain A, 3 interactions with chain B Hydrogen bonds: A:S.185, B:Q.160, B:S.162, B:S.162 GOL.3: 7 residues within 4Å: Chain A: Y.102, L.103 Chain B: W.32, Y.49, E.50, Y.91 Ligands: GOL.1 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:E.50, B:Y.91

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Barnes, C.O. et al., SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature (2020)

Release Date

2020-10-21

Peptides

C135 Fab Heavy Chain: A
C135 Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C135 Fab Heavy Chain

C135 Fab Light Chain

Related Entries With Identical Sequence